Holen Sie sich die Stockscreener-App
2.73
0.37%
0.02
Handel nachbörslich:
2.73
Cerus Corp Aktie (CERS) Neueste Nachrichten
What’s Fueling New Momentum Across Penny Stock Markets? - Kalkine Media
Q1 2026 Cerus Corp Earnings Call Transcript - GuruFocus
Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG - Insider Monkey
Cerus Corporation (CERS) Q1 2026 Earnings: EPS Surprises to the Upside as Loss NarrowsCrowd Breakout Signals - Newser
Cerus Corp stock (US1570851014): turnaround hopes after sharp rally in blood safety specialist - AD HOC NEWS
Are NYSE Penny Stocks Showing Mixed Financial Strength? - Kalkine Media
Cerus Corp stock (US1570851014): blood safety specialist in focus after Q1 2026 update - AD HOC NEWS
Cerus Corp stock (US1570851014): blood safety specialist back in focus after latest business update - AD HOC NEWS
Cerus Corp stock (US1570851014): Recent 2.21% gain amid mixed signals - AD HOC NEWS
Cerus Is Finding Its Next Gear In Blood Safety - Finimize
Vivek Jayaraman Sells 16,667 Shares of Cerus (NASDAQ:CERS) Stock - MarketBeat
Cerus corp COO Vivek Jayaraman sells $50,001 in common stock By Investing.com - Investing.com Australia
Cerus corp COO Vivek Jayaraman sells $50,001 in common stock - Investing.com
Cerus (CERS) COO sells 16,667 shares in planned 10b5-1 trade - Stock Titan
Cerus Momentum Builds Amid Healthcare Innovation Buzz On Nasdaq Composite - Kalkine Media
Cerus (NASDAQ:CERS) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Cerus Company Profile & Introduction - Moomoo
Cerus (NASDAQ:CERS) Upgraded by Zacks Research to Hold Rating - MarketBeat
Cerus Corporation Reports First Quarter 2026 Financial Results - HarianBasis.co
Cerus (NASDAQ:CERS) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Cerus Corporation Q1 2026 SEC Filing: Financial Statements, Risk Factors, and Management Discussion - Minichart
[144] CERUS CORP SEC Filing - Stock Titan
Insider sale filings: CERS (NASDAQ: CERS) reports restricted stock dispositions - Stock Titan
CERS Upgraded by BTIG -- Price Target Announced at $4.00 - GuruFocus
Cerus (NASDAQ:CERS) Reaches New 12-Month High After Better-Than-Expected Earnings - MarketBeat
Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
CERSCerus Corp Stock Price and Quote - Finviz
BTIG Research Upgrades Cerus (NASDAQ:CERS) to "Buy" - MarketBeat
Cerus Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Cerus Corporation (NASDAQ:CERS) Q1 2026 Earnings Call Transcript - Insider Monkey
Cerus Corp (CERS) Q1 2026 Earnings Call Highlights: Strong Reven - GuruFocus
Cerus (NASDAQ:CERS) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Is Cerus (CERS) 8.6% Undervalued After Q1 2026 Earnings Beat? EP - GuruFocus
Cerus Q1 Earnings Call Highlights - MarketBeat
Cerus (NASDAQ: CERS) grows Q1 2026 revenue and sharply cuts net loss - Stock Titan
Cerus Q1 2026 Earnings Call Transcript - Benzinga
Earnings call transcript: Cerus Corporation Q1 2026 beats EPS forecast - Investing.com
Cerus Corp 1Q 2026: Revenue $59.9M, EPS $(0.01) — 10-Q Summary - TradingView
Cerus Corporation (CERS) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
Cerus Corp (NASDAQ:CERS) Surges on Strong Q1 Beat and Raised Guidance - ChartMill
Cerus: Q1 Earnings Snapshot - San Francisco Chronicle
Cerus Reports Q1 2026 Revenue $59.9M, Product Revenue Up 24% and Raises 2026 Product Guidance - TradingView
Cerus Corporation (NASDAQ: CERS) lifts 2026 outlook after strong Q1 results - Stock Titan
Blood safety company Cerus lifts 2026 forecast after 24% product-sales jump - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market SessionAkanda (NASDAQ:AKAN), American Shared H - Benzinga
Cerus signs four-year supply deal with French blood service - Investing.com
Cerus signs four-year supply deal with French blood service By Investing.com - Investing.com Canada
Cerus wins 4-year deal with French blood network serving 330,000 units - Stock Titan
Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System - Yahoo Finance
CERS SEC FilingsCerus 10-K, 10-Q, 8-K Forms - Stock Titan
Cerus (CERS) to Release Earnings on Thursday - MarketBeat
[ARS] CERUS CORP SEC Filing - Stock Titan
Cerus (NASDAQ: CERS) seeks equity plan approval and board re-election - Stock Titan
Cerus appoints severance agreements for Kevin D. Green, Vivek Jayaraman, Richard Benjamin and Chrystal N. Jensen - TradingView
Cerus (NASDAQ: CERS) sets richer change-of-control severance for executives - Stock Titan
Cerus (CERS) Future Plans | Q4 2025: Below ExpectationsExpert Entry Points - Newser
Cerus (CERS) Stock: Trend Strength Analysis (Momentum Fading) 2026-04-20Hot Community Stocks - newser.com
Sumitomo Mitsui Trust Group Inc. Sells 975,218 Shares of Cerus Corporation $CERS - MarketBeat
Cerus sets April 30 earnings release, 4:30 p.m. ET webcast - Stock Titan
Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026 - Yahoo Finance
1.35%
2.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):